Showing results (91-100 of 236) with videos related to
Sort By:
Pageof 24
Sexually Transmitted Diseases|November 4, 2025
Patterns and correlates of initiation of long-acting injectable cabotegravir for pre-exposure prophylaxis: a case-control analysisRoberto Rossotti, Gabriele Cavazza, Enrico Caruso, et al.HIV Clinical Trials|March 2, 2018
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort<sup/>Antonella d'Arminio Monforte, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2009
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patientsGiulia Morsica, Sabrina Bagaglio, Paola Cicconi, et al.AIDS (London, England)|March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruptionGregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2009
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosisAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonella Castagna, et al.Scandinavian Journal of Infectious Diseases|July 19, 2012
Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: a case-control studyRoberto Rossotti, Maria Cristina Moioli, Leonardo Chianura, et al.Plos One|January 12, 2018
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patientsAnnalisa Saracino, Alessandro Cozzi-Lepri, Milensu Shanyinde, et al.Infection|November 4, 2017
Current and future challenges in HCV: insights from an Italian experts panelMassimo Andreoni, Sergio Babudieri, Savino Bruno, et al.Open Forum Infectious Diseases|January 15, 2021
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected PatientsVincenzo Malagnino, Carlotta Cerva, Antonella Cingolani, et al.Journal of Hepatology|November 26, 2025
A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis CJosep M Llibre, Christoph Boesecke, Juhi Moon, et al.Pageof 24